Silver Book Fact

Visual impairment (compared to no visual impairment) is associated with more than $1,000 in excess annual medical expenses per person.

Frick, Kevin D., Emily W. Gower, John H. Kempen, and Jennifer L. Wolff. Economic Impact of Visual Impairment and Blindness in the United States. Archives of Ophthalmology. 2007; 125(4): 544-50. http://archopht.ama-assn.org/cgi/content/abstract/125/4/544

Reference

Title
Economic Impact of Visual Impairment and Blindness in the United States
Publication
Archives of Ophthalmology
Publication Date
2007
Authors
Frick, Kevin D., Emily W. Gower, John H. Kempen, and Jennifer L. Wolff
Volume & Issue
Volume 125, Issue 4
Pages
544-50
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • In 2001, an estimated 1.4 million age-related macular degeneration (AMD) patients visited physicians or hospitals for treatment of their disease.  
  • The average cost in 2004 per age-related macular degeneration (AMD) patient age 40 and older using medications and vitamins was $110.  
  • The number of Medicare beneficiaries newly diagnosed with wet age-related macular degeneratino (AMD) more than doubled between 1994 and 2006.  
  • The annual direct medical costs (including outpatient, inpatient, and prescription drug services) for Americans age 40 and older with glaucoma is $2.86 billion.  
  • People Affected Worldwide by DR
    By 2030, more than 191 million people around the world will be affected by DR—56 million with vision-threatening DR.